QDDresearch

Nutrien Ltd NTR

MaterialsChemicalsCanada

Last close 96.96 CAD on Nov 1, 2026, +17.2% year to date

Quant rating

Quant rating A+ Rank 14 of 154 in Materials
  1. Growth B 72 of 154
  2. Valuation B 57 of 154
  3. Quality B 47 of 154
  4. Revisions B 32 of 154
  5. Momentum B 46 of 154

Wall Street consensus Buy (2.26)Average target 110.47 CAD +13.9%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
202520242023202220215Y avg
Revenue (mil)36,89737,34838,48551,32935,011–
Revenue growth−1.2%−3.0%−25.0%46.6%31.5%6.8%
EPS (basic, normalized)6.244.946.0017.757.90–
EPS growth26.4%−17.6%−66.2%124.7%––
Gross margin30.1%28.4%28.2%38.3%32.7%31.5%
Net margin8.4%2.6%4.3%20.2%11.4%9.4%
ROE9.1%2.7%4.9%31.0%13.7%12.3%
Balance sheet, last quarter
Cash & short-term investments (mil)1,307
Current ratio1.39x
Long-term debt (mil)14,764
Net debt (mil)16,811
Total equity (mil)36,768
Net debt / equity0.46x
Net debt / EBITDA2.03x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2025 actual 36,897−1.2%1.7x 8,280+10.9%7.6x 6.24+26.4%15.5x
2026 38,679+4.8%1.6x 8,815+6.5%7.1x 6.93+10.9%14.0x
2027 38,626−0.1%1.6x 8,841+0.3%7.1x 7.12+2.9%13.6x
2028 38,355−0.7%1.6x 8,381−5.2%7.5x 6.70−5.9%14.5x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
202638,6790.0%−1.1%+2.4%6.93−1.6%−14.5%−18.3%
202738,626+0.1%+1.2%+4.4%7.12+0.7%−2.1%−4.0%
202838,355−0.8%+2.9%+4.2%6.70+6.5%−1.4%−7.4%

Earnings surprises EPS beat in 1 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales reported (mil)5,1519,9165,0854,8644,87410,1985,7355,1425,80210,609
Sales mean (mil)5,30510,7775,2685,0935,18410,4475,6065,2865,24610,296
Surprise−2.9%−8.0%−3.5%−4.5%−6.0%−2.4%+2.3%−2.7%+10.6%+3.0%
EPS reported0.462.340.390.310.112.650.970.830.512.61
EPS mean0.392.210.460.350.312.400.950.950.532.71
Surprise+19.4%+5.8%−15.3%−10.9%−64.1%+10.6%+2.0%−12.8%−3.8%−3.7%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
NTR Nutrien Ltd46.3B2.03x8.4%1.28x14.0x13.6x7.1x7.1x
LIN Linde PLC330.2B1.82x20.3%5.99x28.7x26.3x18.3x17.2x
AIRP L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA180.5B–13.0%4.34x27.9x25.2x15.0x13.8x
SHW Sherwin-Williams Co112.4B2.50x10.9%20.21x27.6x25.1x18.9x17.8x
ECL Ecolab Inc.118.9B3.22x12.9%8.15x37.1x32.3x22.2x19.8x
APD Air Products and Chemicals, Inc.98.6B3.82x−3.2%5.08x23.6x22.0x16.4x15.4x
Mean2.68x10.4%7.51x26.5x24.1x16.3x15.2x
Median2.50x11.9%5.53x27.8x25.1x17.4x16.3x

Technical analysis

  • 1M−4.2%
  • 3M−0.3%
  • 1Y+26.1%
  • 3Y+41.4%

Financial statements in millions of CAD

Income statement, Nutrien Ltd, fiscal years, most recent first
202520242023202220212020
Total revenue36,89737,34838,48551,32935,01126,616
Cost of revenue25,79726,75127,63031,66323,55520,056
Gross profit11,10010,59710,85419,66611,4576,560
Selling, general & administrative expenses4,7244,9634,3504,4523,9563,651
Research & development––––––
Depreciation/amortization1,0251,1251,0331,041900572
Interest expense (income), operating−452342−13.2−318−59.4−70.0
Unusual expense (income)2441,2291,413−984332900
Other operating expenses431269436831467383
Operating income5,1272,6693,63614,6455,8611,124
Net interest income (expense)−856−942−915−622−595−579
Gain (loss) on sale of assets––––––
Other non-operating income (expense)−86.5−93.5−135−1410−58.6
Net income before taxes4,1841,6342,58513,8825,266486
Provision for taxes1,0326278873,4671,250−98.0
Minority interest−41.2−37.4−31.8−36.6−32.8–
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items3,1119691,66610,3793,984584
Extraordinary items––––––
Net income3,1119691,66610,3793,984584
EBIT, normalized4,9204,2415,03613,3436,1341,954
EBITDA, normalized8,1717,6047,87716,0898,5994,486
Basic EPS, normalized6.244.946.0017.757.90–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.